Solventum Corporation(SOLV)

New York Stock Exchange
Sector: Healthcare | Industry: Medical - Care Facilities
Solventum Corporation logo

Solventum Corporation, a healthcare company, engages in the developing, manufacturing, and commercializing a portfolio of solutions to address critical customer and patient needs. It operates through four segments: Medsurg, Dental Solutions, Health Information Systems, and Purification and Filtration. The Medsurg segment is a provider of solutions including advanced wound care, I.V. site management, sterilization assurance, temperature management, surgical supplies, stethoscopes, and medical electrodes. The Dental Solutions segment provides a comprehensive suite of dental and orthodontic products including brackets, aligners, restorative cements, and bonding agents. The Health Information Systems provides software solutions including computer-assisted, physician documentation, direct-to-bill and coding automation, classification methodologies, speech, recognition, and data visualization platforms. The Purification and Filtration segment provides purification and filtration technologies including filters, purifiers, cartridges, and membranes. The company was incorporated in 2023 and is based in Saint Paul, Minnesota.

Latest News & Analysis

Solventum (SOLV) revolutionizes digital dentistry, aiming for growth despite debt and margin challenges. Explore strategic partnerships, earnings outlook, and market impact.
Apr 9, 2025

Solventum (SOLV): Digital Dentistry Disruption, Earnings Outlook, and Growth Strategy

Analysis of Solventum (SOLV): Digital dentistry disruption, earnings outlook, debt management, and strategic growth initiatives in the healthcare sector.

Read more →
Solventum (SOLV) stock analysis: New product launch, Attest eBowie-Dick Test System, investor day preview, financial outlook, and strategic insights.
Mar 17, 2025

Solventum (SOLV) Stock Analysis: New Products, Investor Day, and Financial Outlook

Solventum (SOLV) navigates post-spin-off challenges with new product launches and strategic shifts amidst margin concerns and activist investor influence.

Read more →
Solventum (SOLV) analysis: Earnings, Trian's influence, Thermo Fisher deal impacts, and future strategies.
Mar 13, 2025

Solventum (SOLV): Earnings, Trian's Influence, and the Thermo Fisher Deal

Solventum (SOLV) navigates post-spin-off challenges: Q4 earnings beat, Trian's influence, Thermo Fisher deal impact, and margin recovery strategies.

Read more →
Solventum Investor Day Preview: Analysis of earnings, strategy, Trian Fund influence, and Solventum's future growth potential. [SOLV]
Feb 28, 2025

Solventum Investor Day Preview: Earnings, Strategy, and Trian's Influence

Solventum's Investor Day preview: Earnings, strategy, and Trian's influence. Q4 earnings beat expectations amid strategic shifts. A deep dive into future growth drivers.

Read more →
Solventum Strategic Transformation: Analysis of divestitures, investor influence, and future prospects in the healthcare industry. Key financial ratios and revenue estimates included.
Feb 27, 2025

Solventum's Transformation: Thermo Fisher Deal, Trian's Influence

Solventum navigates strategic shifts: Thermo Fisher deal, Trian's influence, and Investor Day preview. Debt reduction and AI growth are key focuses.

Read more →
Solventum strategic transformation: Thermo Fisher deal, Trian Fund influence, and investor outlook.
Feb 26, 2025

Solventum's Strategic Transformation: Thermo Fisher, Trian & Investor Day

Solventum's strategic transformation includes a Thermo Fisher deal and Trian Fund influence. Upcoming Investor Day insights will shape its future. A deep dive into $SOLV.

Read more →
Solventum strategic shift: Thermo Fisher deal, Trian's influence, and focus on core growth areas.
Feb 25, 2025

Solventum's $4.1B Thermo Fisher Deal: Strategic Shift and Trian's Influence

Solventum sells its Purification & Filtration business to Thermo Fisher for $4.1 billion. Analysis of strategic shift, debt reduction, and Trian Fund's involvement.

Read more →
Stylized DNA helix and medical cross representing healthcare.
Feb 18, 2025

Solventum (SOLV): Post-Spinoff Outlook & Trian Influence

A deep analysis on Solventum’s post-spinoff performance, activist investor pressure, innovative products, and market challenges.

Read more →